top of page

Topic: Tumours of the endocrine organs

CPGs graded Strong

M. Dietlein , W. Eschner et al. (2016). DGN-Handlungsempfehlung (S1-Leitlinie): Radio iodtherapie beim differenzierten Schilddrüsenkarzinom Verfahrensanweisung – Version 4 (Procedure guidelines for radioiodine therapy of differentiated thyroid cancer Version). Stand: 10/2015 – AWMF-Registernummer: 031-002 /Deutsche Gesellschaft für Nuklearmedizin (DGN).

https://www.nuklearmedizin.de/leistungen/leitlinien/docs/031-002l_S1_Radioiodtherapie_differenziertes_Schilddruesenkarziom_2015-10.pdf

Wörmann B, Aebi S, Balic Met al. (2016). Leitlinien: Mammakarzinom des Mannes (Male breast carcinoma Guidelines). ICD10: C50.9/ Recommendations from the society for diagnosis and therapy of haematological and oncological diseases. German Association of Hematology and Medical Oncology (DGHO).

https://www.onkopedia.com/de/onkopedia/guidelines/mammakarzinom-des-mannes/@@view/pdf/20180918-051944.pdf

CPGs graded Moderate

Dralle, H., Musholt, T.J., Schabram, J. et al. (2013). German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg (2013) 398:347–375. DOI 10.1007/s00423-013-1057-6. http://www.spcir.com/wp-content/uploads/pdf/formacao/German_Association_of_Endocrine_Surgeons_Practice.pdf

Unbenannt.JPG

Work Package 6

_project_management_standards.jpg
bottom of page